HY2Care Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.15M

  • Investors
  • 6

HY2Care General Information

Description

Manufacturer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel are composed of a mixture of natural polymer conjugates that cross-link in a mild enzymatic reaction, enabling clinicians to treat patients with functional repair of cartilage defects in the knee.

Contact Information

Website
www.hy2care.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HY2Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 30-Apr-2019 $4.15M 00.000 Completed Generating Revenue
4. Angel (individual) 01-Jan-2017 000.00 Completed Generating Revenue
3. Grant 04-Aug-2016 000.00 000.00 Completed Generating Revenue
2. Accelerator/Incubator 13-Apr-2015 $16.2K $16.2K Completed Generating Revenue
1. Grant Completed Startup
To view HY2Care’s complete valuation and funding history, request access »

HY2Care Patents

HY2Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11414483-B2 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Active 18-Jan-2018 000000000 00
US-20200347125-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Active 18-Jan-2018 000000000
EP-3740525-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Pending 18-Jan-2018 000000000
CA-3088978-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Pending 18-Jan-2018 000000000
EP-3067069-A1 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers Active 11-Nov-2009 A61L27/3817 0
To view HY2Care’s complete patent history, request access »

HY2Care Executive Team (6)

Name Title Board Seat Contact Info
Sanna Severins Chief Operating Officer & Co-Director
Marcel Karperien Co-Founder, Chief Scientific Officer & Supervisory Board Member
Johan Jansen CFO
Leo Smit Chief Executive Officer
You’re viewing 4 of 6 executive team members. Get the full list »

HY2Care Board Members (3)

Name Representing Role Since
Georges de Meris Self Chairman of Supervisory Board 000 0000
Luc Starmans Ph.D Brightlands Venture Partners Supervisory Board Member 000 0000
Marcel Karperien HY2Care Co-Founder, Chief Scientific Officer & Supervisory Board Member 000 0000
To view HY2Care’s complete board members history, request access »

HY2Care Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HY2Care Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brightlands Venture Partners Venture Capital Minority 000 0000 000000 0
ReumaNederland Corporation Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Startupbootcamp Accelerator/Incubator Minority 000 0000 000000 0
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

HY2Care FAQs

  • When was HY2Care founded?

    HY2Care was founded in 2014.

  • Who is the founder of HY2Care?

    Marcel Karperien and Chris Cardinaels are the founders of HY2Care.

  • Who is the CEO of HY2Care?

    Leo Smit is the CEO of HY2Care.

  • Where is HY2Care headquartered?

    HY2Care is headquartered in Geleen, Netherlands.

  • What is the size of HY2Care?

    HY2Care has 12 total employees.

  • What industry is HY2Care in?

    HY2Care’s primary industry is Other Devices and Supplies.

  • Is HY2Care a private or public company?

    HY2Care is a Private company.

  • What is HY2Care’s current revenue?

    The current revenue for HY2Care is 00000.

  • How much funding has HY2Care raised over time?

    HY2Care has raised $4.17M.

  • Who are HY2Care’s investors?

    Brightlands Venture Partners, ReumaNederland, Horizon 2020 SME Instrument, Startupbootcamp, and European Innovation Council Fund are 5 of 6 investors who have invested in HY2Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »